Lv1
40 积分 2025-04-11 加入
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
6天前
已完结
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
6天前
已完结
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
7天前
已完结
皖公网安备34019202002308
